New data from Phase 3 studies showed superior SVR (viral cure) rates achieved with telaprevir-based combination therapy in people with hepatitis C, regardless of race or stage of liver disease

Age-standardised disability-adjusted life year...Image via Wikipedia
New data from Phase 3 studies showed superior SVR (viral cure) rates achieved with telaprevir-based combination therapy in people with hepatitis C, regardless of race or stage of liver disease
Enhanced by Zemanta

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)